UTI: Universal Technical Institute Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Universal Technical Institute Inc (UTI).

OverviewDividends

$874.98M Market Cap.

As of 05/09/2025 5:00 PM ET (MRY) • Disclaimer

UTI Market Cap. (MRY)


UTI Shares Outstanding (MRY)


UTI Assets (MRY)


Total Assets

$744.58M

Total Liabilities

$484.34M

Total Investments

$36.27M

UTI Income (MRY)


Revenue

$732.69M

Net Income

$42.00M

Operating Expense

$289.27M

UTI Cash Flow (MRY)


CF Operations

$85.89M

CF Investing

-$24.00M

CF Financing

-$51.34M

UTI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$744,575,000 (0.53%)

$740,685,000 (33.96%)

$552,911,000 (7.87%)

$512,570,000 (15.97%)

Assets Current

$221,951,000 (8.28%)

$204,985,000 (50.78%)

$135,953,000 (-25.87%)

$183,392,000 (1.78%)

Assets Non-Current

$522,624,000 (-2.44%)

$535,700,000 (28.48%)

$416,958,000 (26.67%)

$329,178,000 (25.74%)

Goodwill & Intangible Assets

$46,688,000 (-1.57%)

$47,434,000 (52.65%)

$31,074,000 (272.32%)

$8,346,000 (1.51%)

Shareholders Equity

$260,231,000 (15.16%)

$225,967,000 (4.91%)

$215,397,000 (14.25%)

$188,530,000 (6.80%)

Property Plant & Equipment Net

$423,575,000 (-4.39%)

$443,003,000 (27.91%)

$346,330,000 (23.19%)

$281,126,000 (29.31%)

Cash & Equivalents

$167,472,000 (6.72%)

$156,924,000 (124.19%)

$69,996,000 (-52.05%)

$145,977,000 (64.17%)

Accumulated Other Comprehensive Income

$1,106,000 (-55.10%)

$2,463,000 (11.30%)

$2,213,000 (893.19%)

-$279,000 (0%)

Deferred Revenue

$92,538,000 (7.93%)

$85,738,000 (58.12%)

$54,223,000 (-5.94%)

$57,648,000 (41.66%)

Total Investments

$36,267,000 (18.24%)

$30,672,000 (-48.14%)

$59,149,000 (93.39%)

$30,586,000 (-53.42%)

Investments Current

$0 (0%)

$0 (0%)

$28,918,000 (0%)

$0 (0%)

Investments Non-Current

$36,267,000 (18.24%)

$30,672,000 (1.46%)

$30,231,000 (-1.16%)

$30,586,000 (10.78%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$37,296,000 (19.72%)

$31,152,000 (41.02%)

$22,091,000 (-2.64%)

$22,689,000 (-44.11%)

Trade & Non-Trade Payables

$83,866,000 (19.91%)

$69,941,000 (4.89%)

$66,680,000 (22.58%)

$54,397,000 (4.83%)

Accumulated Retained Earnings (Deficit)

$38,509,000 (547.65%)

$5,946,000 (554.93%)

-$1,307,000 (94.06%)

-$21,996,000 (33.29%)

Tax Assets

$3,563,000 (-5.44%)

$3,768,000 (11.98%)

$3,365,000 (0%)

$0 (0%)

Tax Liabilities

$4,696,000 (608.30%)

$663,000 (0%)

$0 (0%)

$674,000 (0.00%)

Total Debt

$294,745,000 (-15.70%)

$349,624,000 (66.65%)

$209,799,000 (5.94%)

$198,029,000 (25.32%)

Debt Current

$24,907,000 (-0.36%)

$24,998,000 (77.62%)

$14,074,000 (-5.87%)

$14,951,000 (-37.17%)

Debt Non-Current

$269,838,000 (-16.88%)

$324,626,000 (65.86%)

$195,725,000 (6.91%)

$183,078,000 (36.40%)

Total Liabilities

$484,344,000 (-5.90%)

$514,718,000 (52.50%)

$337,514,000 (4.16%)

$324,040,000 (22.07%)

Liabilities Current

$204,963,000 (10.97%)

$184,700,000 (34.11%)

$137,722,000 (3.77%)

$132,718,000 (9.11%)

Liabilities Non-Current

$279,381,000 (-15.34%)

$330,018,000 (65.18%)

$199,792,000 (4.43%)

$191,322,000 (33.03%)

UTI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$732,687,000 (20.63%)

$607,408,000 (45.05%)

$418,765,000 (24.97%)

$335,083,000 (11.41%)

Cost of Revenue

$384,529,000 (16.57%)

$329,870,000 (59.18%)

$207,233,000 (24.23%)

$166,818,000 (6.98%)

Selling General & Administrative Expense

$289,267,000 (12.93%)

$256,139,000 (35.41%)

$189,158,000 (23.38%)

$153,318,000 (3.11%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$289,267,000 (12.93%)

$256,139,000 (35.41%)

$189,158,000 (23.38%)

$153,318,000 (3.11%)

Interest Expense

$9,471,000 (-1.92%)

$9,656,000 (382.32%)

$2,002,000 (448.49%)

$365,000 (3550.00%)

Income Tax Expense

$14,229,000 (146.82%)

$5,765,000 (206.62%)

-$5,407,000 (-998.17%)

$602,000 (105.68%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$42,001,000 (240.86%)

$12,322,000 (-52.33%)

$25,848,000 (77.27%)

$14,581,000 (82.08%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$42,001,000 (240.86%)

$12,322,000 (-52.33%)

$25,848,000 (77.27%)

$14,581,000 (82.08%)

Preferred Dividends Income Statement Impact

$3,952,000 (-49.21%)

$7,781,000 (-40.17%)

$13,006,000 (46.18%)

$8,897,000 (39.04%)

Net Income Common Stock

$38,049,000 (737.90%)

$4,541,000 (-64.64%)

$12,842,000 (125.93%)

$5,684,000 (253.26%)

Weighted Average Shares

$49,429,000 (45.44%)

$33,985,000 (2.31%)

$33,218,000 (1.38%)

$32,766,000 (9.91%)

Weighted Average Shares Diluted

$50,851,000 (47.48%)

$34,479,000 (2.18%)

$33,743,000 (1.87%)

$33,123,000 (10.00%)

Earning Before Interest & Taxes (EBIT)

$65,701,000 (136.82%)

$27,743,000 (23.62%)

$22,443,000 (44.35%)

$15,548,000 (701.70%)

Gross Profit

$348,158,000 (25.45%)

$277,538,000 (31.20%)

$211,532,000 (25.71%)

$168,265,000 (16.18%)

Operating Income

$58,891,000 (175.20%)

$21,399,000 (-4.36%)

$22,374,000 (49.69%)

$14,947,000 (486.13%)

UTI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$24,002,000 (45.53%)

-$44,066,000 (67.26%)

-$134,597,000 (-486.45%)

-$22,951,000 (49.84%)

Net Cash Flow from Financing

-$51,345,000 (-162.73%)

$81,846,000 (550.35%)

$12,585,000 (-49.30%)

$24,824,000 (-42.39%)

Net Cash Flow from Operations

$85,895,000 (74.77%)

$49,148,000 (6.77%)

$46,031,000 (-16.59%)

$55,185,000 (400.23%)

Net Cash Flow / Change in Cash & Cash Equivalents

$10,548,000 (-87.87%)

$86,928,000 (214.41%)

-$75,981,000 (-233.16%)

$57,058,000 (582.19%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$16,381,000 (37.78%)

-$26,326,000 (-9603.97%)

$277,000 (6.13%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$29,000,000 (200.62%)

-$28,821,000 (-176.55%)

$37,651,000 (198.08%)

Capital Expenditure

-$24,298,000 (57.14%)

-$56,685,000 (28.65%)

-$79,450,000 (-29.60%)

-$61,306,000 (-566.51%)

Issuance (Repayment) of Debt Securities

-$36,518,000 (-141.64%)

$87,696,000 (376.74%)

$18,395,000 (-39.68%)

$30,495,000 (30903.03%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,560,000 (122.45%)

$3,848,000 (-11.28%)

$4,337,000 (150.26%)

$1,733,000 (-16.56%)

Depreciation Amortization & Accretion

$51,185,000 (11.71%)

$45,819,000 (39.79%)

$32,777,000 (10.61%)

$29,632,000 (-17.86%)

UTI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

47.50% (3.94%)

45.70% (-9.50%)

50.50% (0.60%)

50.20% (4.15%)

Profit Margin

5.20% (642.86%)

0.70% (-77.42%)

3.10% (82.35%)

1.70% (240.00%)

EBITDA Margin

16.00% (32.23%)

12.10% (-8.33%)

13.20% (-2.22%)

13.50% (21.62%)

Return on Average Equity (ROAE)

15.90% (657.14%)

2.10% (-65.57%)

6.10% (90.62%)

3.20% (220.00%)

Return on Average Assets (ROAA)

5.30% (783.33%)

0.60% (-75.00%)

2.40% (100.00%)

1.20% (200.00%)

Return on Sales (ROS)

9.00% (95.65%)

4.60% (-14.81%)

5.40% (17.39%)

4.60% (611.11%)

Return on Invested Capital (ROIC)

9.80% (157.89%)

3.80% (-13.64%)

4.40% (15.79%)

3.80% (642.86%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

21.12 (-67.24%)

64.46 (362.13%)

13.95 (-64.92%)

39.77 (-60.86%)

Price to Sales Ratio (P/S)

1.1 (133.90%)

0.47 (8.56%)

0.43 (-34.64%)

0.66 (31.15%)

Price to Book Ratio (P/B)

3.36 (166.19%)

1.26 (48.07%)

0.85 (-27.53%)

1.18 (25.48%)

Debt to Equity Ratio (D/E)

1.86 (-18.31%)

2.28 (45.37%)

1.57 (-8.84%)

1.72 (14.30%)

Earnings Per Share (EPS)

0.77 (492.31%)

0.13 (-66.67%)

0.39 (129.41%)

0.17 (240.00%)

Sales Per Share (SPS)

14.82 (-17.06%)

17.87 (41.77%)

12.61 (23.27%)

10.23 (1.37%)

Free Cash Flow Per Share (FCFPS)

1.25 (661.26%)

-0.22 (77.93%)

-1.01 (-437.97%)

-0.19 (-401.61%)

Book Value Per Share (BVPS)

5.26 (-20.82%)

6.65 (2.54%)

6.48 (12.69%)

5.75 (-2.82%)

Tangible Assets Book Value Per Share (TABVPS)

14.12 (-30.79%)

20.4 (29.86%)

15.71 (2.08%)

15.39 (5.77%)

Enterprise Value Over EBIT (EV/EBIT)

16 (-15.79%)

19 (26.67%)

15 (-21.05%)

19 (121.11%)

Enterprise Value Over EBITDA (EV/EBITDA)

9.14 (27.80%)

7.15 (20.40%)

5.94 (-9.64%)

6.58 (-5.63%)

Asset Turnover

1.02 (21.68%)

0.83 (6.91%)

0.78 (8.47%)

0.72 (0.42%)

Current Ratio

1.08 (-2.43%)

1.11 (12.46%)

0.99 (-28.58%)

1.38 (-6.68%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$61,597,000 (917.26%)

-$7,537,000 (77.45%)

-$33,419,000 (-445.97%)

-$6,121,000 (-433.75%)

Enterprise Value (EV)

$1,068,733,144 (103.07%)

$526,295,980 (60.39%)

$328,137,124 (10.45%)

$297,096,019 (27.30%)

Earnings Before Tax (EBT)

$56,230,000 (210.89%)

$18,087,000 (-11.52%)

$20,441,000 (34.63%)

$15,183,000 (685.31%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$116,886,000 (58.89%)

$73,562,000 (33.22%)

$55,220,000 (22.22%)

$45,180,000 (34.89%)

Invested Capital

$620,197,000 (-11.56%)

$701,251,000 (33.85%)

$523,918,000 (23.69%)

$423,558,000 (11.11%)

Working Capital

$16,988,000 (-16.25%)

$20,285,000 (1246.69%)

-$1,769,000 (-103.49%)

$50,674,000 (-13.44%)

Tangible Asset Value

$697,887,000 (0.67%)

$693,251,000 (32.85%)

$521,837,000 (3.49%)

$504,224,000 (16.25%)

Market Capitalization

$874,980,144 (206.47%)

$285,499,980 (55.42%)

$183,695,124 (-17.22%)

$221,895,019 (33.94%)

Average Equity

$238,603,000 (7.93%)

$221,062,000 (5.22%)

$210,095,750 (16.64%)

$180,122,750 (9.36%)

Average Assets

$721,279,250 (-0.79%)

$727,052,250 (35.64%)

$536,021,000 (15.12%)

$465,628,000 (10.95%)

Invested Capital Average

$673,275,500 (-8.44%)

$735,308,750 (44.91%)

$507,416,750 (22.44%)

$414,413,250 (17.36%)

Shares

53,811,817 (57.95%)

34,069,210 (0.89%)

33,767,486 (2.87%)

32,824,707 (0.66%)